CHAM
APLS

Clear Harbor Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History

Clear Harbor Asset Management’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$805K – 454
2026
Q1 		$805K Buy
+20,000
New +$431K 0.06% 235

Other funds holding APLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Clear Harbor Asset Management's APLS Position: Q2 2026 in Review

Clear Harbor Asset Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 20,000 shares — an estimated $805K sold.

Clear Harbor Asset Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $805K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Clear Harbor Asset Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Clear Harbor Asset Management sold 20,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $805K.
  • Clear Harbor Asset Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Clear Harbor Asset Management's Apellis Pharmaceuticals position peaked at $805K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.